Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
Open-market buys, last 90 days
$1,681,140
in 2 filings
Open-market sales, last 90 days
$425,829
in 1 filing, $426K under 10b5-1 plans

Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion +6,172 $3.56 $22K 18,277
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Shares withheld for taxes −1,829 $9.53 $17K 16,448
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion +3,703 $3.52 $13K 20,151
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Shares withheld for taxes −1,098 $9.53 $10K 19,053
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion +3,115 $3.73 $12K 22,168
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Shares withheld for taxes −923 $9.53 $9K 21,245
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion +7,973 $2.68 $21K 29,218
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Shares withheld for taxes −1,687 $9.53 $16K 27,531
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion +785 $2.68 $2K 28,316
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Shares withheld for taxes −167 $9.53 $2K 28,149
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Sale −6,149 $9.33 $57K 22,000
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion · Stock Option (Right to Buy) −411 0
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion · Stock Option (Right to Buy) −2,057 0
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion · Stock Option (Right to Buy) −1,028 0
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion · Stock Option (Right to Buy) −5,144 0
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion · Stock Option (Right to Buy) −6,172 0
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion · Stock Option (Right to Buy) −3,703 0
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion · Stock Option (Right to Buy) −3,115 1,000
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion · Stock Option (Right to Buy) −7,973 4,372
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion · Stock Option (Right to Buy) −785 243

Page 37 of 42 · 836 trades